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Abstract
A 67-year-old man was diagnosed with rectal cancer. The tumor invaded the subserosal layer, but it was not large,
and there was no sign of obstruction. Neo-adjuvant chemotherapy reduced the size of the tumor. The patient was
admitted to our hospital for surgery. For mechanical bowel preparation, he ingested 34 g of magnesium citrate
(Magcorol P®), but then developed severe shock, a disturbance of consciousness, and acidemia, and he required
catecholamines and mechanical ventilation. X-ray, CT, and laboratory tests revealed ischemic colitis, toxic
megacolon, and hypermagnesemia (16.3 mg/dL). After 2 days of temporary hemodialysis and an enema to reduce
his blood magnesium concentration, he recovered and left the intensive care unit. However, the left side of his colon
had suffered ischemic damage and become irreversibly atrophied. One month later, he underwent laparoscopic
abdominoperineal resection and left-side colectomy for the rectal cancer and severe ischemic colitis of the left side of
the colon. Histopathology confirmed the rectal cancer with a grade 2 chemotherapeutic effect and severe ischemic
colitis of the left side of the colon. Hence, the present case suggests that severe ischemic colitis, toxic megacolon, and
hypermagnesemia can occur after taking a magnesium laxative without obstruction of the intestine.
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Background
Hypermagnesemia is considered to be very rare [1]; it is
usually caused by a laxative overdose, and it may occur
in patients with kidney dysfunction. In many cases, se-
vere shock occurs; thus, early diagnosis and proper ther-
apy are necessary to save the patient’s life. Ischemic
colitis is caused by a reduction in blood flow to the
colon [2]. Patient diagnosis and treatment can be chal-
lenging, since colonic ischemia often occurs in patients
who are debilitated and have multiple medical problems.
Toxic megacolon is a potentially lethal complication of
inflammatory bowel disease (IBD) or colitis due to Clos-
tridium difficile infection, which is characterized by total
or segmental nonobstructive colonic dilatation plus sys-
temic toxicity [3–5].
We present a case of a patient with potentially lethal
hypermagnesemia accompanied by ischemic colitis and
toxic megacolon who took a laxative as part of surgical
pretreatment. To the best of our knowledge, this is the
first report in the literature of a triplet of hypermagnese-
mia, ischemic colitis, and toxic megacolon resulting
from ingestion of a preoperative laxative.
Case presentation
The patient was a 67-year-old man. He had experienced
bloody stool and anal pain for 1 year and then visited
our hospital. Colonoscopic examination showed a locally
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advanced type 2 rectal tumor that had invaded the sub-
serosal layer at the Rb portion, and a CT scan revealed
several swollen lymph nodes. There was no sign of me-
tastasis to other organs. The patient’s past medical his-
tory was significant for hypertension and slight renal
dysfunction (blood urea nitrogen (BUN), 10 mg/dL; cre-
atinine, 1.23 mg/dL; and eGFR was 52.8, chronic kidney
disease (CKD) stage 3a). To reduce the size of the tumor,
we treated the patient with four courses of neo-adjuvant
chemotherapy with the SOX regimen (TS-1 120 mg/body
and oxaliplatin 80 mg/m2), and he completed the treat-
ment without any adverse events. Preoperative examin-
ation revealed that the tumor had decreased more than
30 % in diameter, and the response was regarded as a
“partial response” by RECIST criteria [6]. There was no
obstruction, and minimal tumor at the rectum by colon-
oscopy, and his nodes had also decreased by CT scan.
He was admitted to undergo a laparoscopic abdomino-
perineal resection, and, for mechanical bowel prepar-
ation (MBP), he received 34 g of magnesium citrate
(Magcorol P®; containing 2.71 g of magnesium (Mg)) or-
ally at 2:00 PM, day 0. Three hours later, he had only
scant excrement, and he felt abdominal distention and
muscle weakness in his legs. In spite of additional
anthraquinone laxatives, he could not get excrement.
On day 1, at 2:00 AM, he was lethargic and did not re-
spond well to verbal stimuli. His systolic blood pressure
(BP) was less than 55 mmHg, and his heart rate (HR)
was 75/min (Fig. 2). The electrocardiogram showed the
findings of first-degree atrioventricular block, prolonged
PR interval (0.281 ms), and slightly prolonged QRS
interval (0.118 ms). Intravenous epinephrine and dopa-
mine were started to restore normal BP, but the effect
was limited, and the BP soon fell again. Next, the patient
was transferred to the intensive care unit (ICU) and was
intubated. Under dopamine (10 μg/kg/min), dobutamine
(5 μg/kg/min), and norepinephrine (0.7 μg/kg/min), his
systolic BP was 75/40 mmHg, his HR was 70/min, and his
abdomen was soft but distended and tympanic, but there
was no muscular defense. Emergency CT and abdominal
X-ray examinations revealed diffuse and marked dilatation
of the large-bowel loops, with fecal impaction 6 cm in
diameter at the sigmoid colon (Fig. 1), and no free air in
the abdominal cavity. His head CT scan was of normal
finding, as was his echocardiography findings. Digital rec-
tal palpation revealed no anal or rectal stenosis, and there
was enough room to pass the stool. We drained the fecal
impaction by intestinal lavage and a transanal tube (12 Fr
silicone tube). A stool culture revealed normal flora and
no C. difficile or other toxigenic bacteria. A large volume
of liquid excrement was removed, but his abdomen was
still distended, and his BP was still low, even though sev-
eral catecholamines were on board. At first, our diagnosis
was functional fecal ileus with an infection due to “bacter-
ial translocation,” and we thought that the patient devel-
oped septic shock. Despite his markedly low BP, his HR
was not increased; relative bradycardia continued. Then,
the presence of hypermagnesemia was suspected. The pa-
tient’s serum Mg level on day 3 was 6.4 mg/dL, and blood
drawn at day 1 showed a markedly elevated serum Mg
concentration of 16.3 mg/dL (Fig. 2). The serum Mg level
at admission was normal (1.8 mg/dL), and the diagnosis of
symptomatic hypermagnesemia was confirmed. Calcium
gluconate was infused to antagonize the effects of
hypermagnesemia. To reduce the serum Mg concentra-
tion, we performed temporary hemodialysis. After
2 days, hemodialysis and daily intestinal lavage enabled
the serum Mg level to decrease to almost the standard
level, and the patient’s hemodynamics also dramatically
improved. Intravenous catecholamines were gradually
Fig. 1 Clinical course and value of the patient. Mg magnesium, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure
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withdrawn, and the patient was extubated at day 5.
Though his hemodynamics were improved, and the in-
flammation was gone, his abdomen remained distended.
On day 15, colonoscopy revealed that the mucous mem-
brane was sloughed and the sigmoid colon had an ulcer
that covered the entire circumference, similar to the se-
vere stage of IBD (Fig. 3). The examination could not
progress beyond the sigmoid descending colon junction
because stenosis of the descending colon made it too
tight for the scope to pass. On day 32, a contrast enema
examination revealed notable stenosis on the left side of
the transverse colon to the descending colon (Fig. 4).
These findings confirmed the diagnosis of ischemic col-
itis. The patient tried oral intake, but just a liquid nutri-
tional supplement caused a stomachache and bloody
diarrhea. Subsequently, he ingested only liquid water
and was given intravenous alimentation. While waiting
for recovery of his general condition, on day 52, he
underwent laparoscopic abdominoperineal resection
with left-side colectomy with D3 lymph node dissection.
Laparoscopic observation revealed that the entire trans-
verse colon and descending colon were severely nar-
rowed. Pathological findings showed advanced rectal
cancer, and at the transverse colon and descending
colon, a longitudinal ulcer on the opposite of the mes-
enteric attached side, and severe stenosis with massive
Fig. 2 Abdominal X-ray examination revealed 6-cm dilatation of the
sigmoid colon with fecal impaction
Fig. 3 Colonoscopy showed a severe ulcer and pseudomembrane
at the descending colon
Fig. 4 Contrast enema examination revealed significant stenosis on
the left side of the transverse colon to the descending colon
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invasion of inflammatory cells within the whole thick-
ness of the colon wall. The findings were comparable to
those of ischemic colitis (Fig. 5). The patient had a good
postoperative course and was able to eat normal foods.
He was discharged on day 72 (postoperative day 20)
without any postoperative complications.
Discussion
Magnesium (Mg) is the fourth most abundant cation in
the human body and the second most abundant intracel-
lular cation, with 67 % in bone, 31 % in intracellular
spaces, and 1–2 % found extracellularly [7]. Mg homeo-
stasis is dependent mainly on gastrointestinal absorption
and renal excretion, and the kidney is the main organ in-
volved in Mg regulation. Renal Mg excretion is very effi-
cient because the thick ascending limb of Henle has the
capacity to completely reject Mg reabsorption under
conditions of hypermagnesemia [8]. Even in the presence
of decreased renal function, the serum Mg level is regu-
lated by a reduction in the gastrointestinal absorption of
Mg [9]. Therefore, hypermagnesemia is most frequently
seen in conjunction with renal insufficiency and inges-
tion of Mg-containing drugs or in patients with small-
bowel hypomotility disorder. Moreover, hypermagnese-
mia can decrease bowel motility by blocking myenteric
neurons and interfering with excitation-contraction
coupling of smooth muscle cells [10]. In addition, hyper-
magnesemia can block the peripheral and autonomic
nervous systems via anatomization of calcium effects,
suppression of acetylcholine release, and reduction of
postsynaptic membrane responsiveness and depress the
conduction system of the heart and sympathetic ganglia
[11]. Thus, the clinical manifestations of hypermagnese-
mia vary according to the serum Mg concentration.
Hypotension, nausea, vomiting, facial flushing, urinary
retention, and ileus occur at levels ranging from 5 to
8 mg/dL, while the absence of the deep tendon reflex
and somnolence and complete heart block occur at
9–12 mg/dL. Respiratory depression, paralysis, and
complete heart block occur at levels >15 mg/dL, and
cardiac arrest occurs in asystole at levels >20 mg/dL
[12, 13]. However, the peak serum Mg concentration
does not correlate with mortality or the severity of intes-
tinal complications [14, 15]. Although our case showed
some manifestations of severe hypermagnesemia, we did
not recognize these manifestations until day 3 because his
clinical manifestations were concurrence of hypermagne-
semia, ischemic colitis, and severe shock. Equivalent to
CKD stage 3a, during preoperative chemotherapy in our
case, renal function was maintained, and there were no
abnormalities of serum electrolytes, even Mg. The patient
presented with a serum creatinine level of 1.19 mg/dL on
day 0 before laxative intake, which was a completely nor-
mal value at hospitalization, and there was no stenosis, in-
cluding rectal, at the site of the tumor. However, a Mg
laxative administered as part of the preoperative prepara-
tions reduced and weakened his colonic motility in inverse
proportions with increased serum Mg, and his colon be-
came dilated such that a lot of Mg might have been
absorbed. Finally, the level to which the serum Mg had in-
creased became critical. Treatment for hypermagnesemia
requires increasing renal Mg excretion through intraven-
ous diuretics, and sometimes, hemodialysis is effective
when kidney function is impaired and the patient is symp-
tomatic from hypermagnesemia. In this case, drainage of
fecal impaction by intestinal lavage was also effective to
reduce the intra-bowel Mg concentration.
Distention of the colon due to decreased bowel motil-
ity could lead to continuous ischemia of the entire thick-
ness of the bowel wall and ultimately induce necrosis of
Fig. 5 Pathological findings showed advanced rectal cancer and significant atrophic changes and a longitudinal ulcer at the transverse colon and
descending colon. The findings were compatible to ischemic colitis
Sugiyama et al. Surgical Case Reports  (2016) 2:18 Page 4 of 5
a part of the colon. Ischemia due to dilation of the colon
may be provoked when there is an increase in intralum-
inal pressure to more than 50 mmHg [16]. Acute colonic
ischemia has a high mortality rate, depending on the
cause of the event, the degree of ischemia, and the ex-
tent of ischemic bowel. Ischemic colitis is likely to de-
velop in the left colon, including the splenic flexure and
sigmoid colon, because of its arterial anatomical features.
In our case, the left side of the transverse colon and the
descending colon became gangrenous, as ischemic col-
itis, despite the fact that the sigmoid colon, which is lo-
cated anatomically close to the inferior mesenteric
artery, showed normal findings.
Toxic megacolon is a rare but severe and potentially
fatal complication of colonic inflammation. Most often,
it is associated with IBD [17] specifically ulcerative col-
itis and, to a much lesser extent, Crohn’s disease [18].
Ischemia and amebic colitis may also produce a toxic
megacolon pattern [19]. Its main characteristics are
radiographic evidence of total or segmental colonic dis-
tension of >6 cm. In this case, the patient had received
an amount of magnesium sodium, and despite the fact
that it was the result of laxative intake, he could not use
his bowels. Orally ingested Mg had stayed in the intes-
tine much longer, and intestinal absorption of Mg might
have been enhanced. Initially, hypermagnesemia oc-
curred and caused bowel hypomotility. Prolonged
hypotension and a pressure effect of fecal impaction on
the intestinal circulation could have induced intestinal
ischemia, and the patient developed toxic megacolon.
Although a portion of the toxic megacolon recovered
from a severe condition to almost normal digestive func-
tion, the damage to his left colon was serious, and hard
sclerotic changes occurred. Finally, he required resec-
tion, and surgery for rectal cancer was performed simul-
taneously. To our knowledge, this is the first case report
to show that administration of mechanical bowel
preparation can lead to the development of three rare
complications: hypermagnesemia, ischemic colitis, and
toxic megacolon.
Conclusions
This case shows that preoperative mechanical bowel
preparation containing magnesium sodium might result
in hypermagnesemia regardless of stenosis and it may
cause life-threatening events, such as ischemic colitis
and toxic megacolon.
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